Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
101 studies found for:    telomerase
Show Display Options
Rank Status Study
1 Completed Pulmonary Fibrosis and Telomerase Mutation Study
Condition: Pulmonary Fibrosis
2 Completed Assessment of Telomerase Activity in Endometrial Tissue and Serum in Endometriosis Patients
Conditions: Endometriosis Ovaries;   Infertility, Female
Interventions: Procedure: Cystectomy;   Procedure: Endometrial sampling;   Procedure: Peripheric blood sampling;   Procedure: Ovarian tissue sampling
3 Recruiting Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment
Condition: GLP-1;Metformin;Telomere-telomerase System;Par-4
Interventions: Drug: Liraglutide;   Drug: Metformin
4 Withdrawn Telomere and Telomerase
Condition: Acute Myeloid Leukemia
Intervention: Genetic: Blood sample
5 Active, not recruiting Rosuvastatin Effect on Telomere-telomerase System in ACS
Conditions: Telomere Shortening;   Telomere Length, Mean Leukocyte;   22q Telomere Deletion Syndrome
Intervention: Drug: rosuvastatin
6 Not yet recruiting Telomerase Activator and Retinal Amyloid
Condition: Alzheimer Disease
Interventions: Dietary Supplement: cycloastragenol;   Dietary Supplement: placebo (for cycloastragenol)
7 Recruiting Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1
Condition: Cancer
Interventions: Other: Biological samples;   Drug: Anti PD1/PDL1 treatment
8 Unknown  Telomerase Activity as a Marker For Mobilization Quality
Conditions: Lymphoma;   Multiple Myeloma
9 Withdrawn Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell Vaccines
Condition: Metastatic Prostate Cancer
Intervention: Biological: hTERT mRNA DC
10 Recruiting Study of Anti-telomerase T CD4 Immunity in Metastatic Lung Cancer
Condition: Lung Cancer
Intervention: Other: Biological samples
11 Recruiting Study of Anti-telomerase T CD4 Immunity in Melanoma
Condition: Melanoma
Intervention: Other: biological samples
12 Completed GV 1001 Immunotherapy in Patients With Non-small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Biological: GV 1001 Telomerase peptide
13 Completed Qigong Intervention Program for Abused Chinese Women
Condition: Abused Women
Interventions: Behavioral: Qigong training;   Other: Wait-list control- Health talks
14 Enrolling by invitation Impact of Lifestyle Changes on Telomeric Activity in Patients With Chronic Pain
Condition: Chronic Pain
Intervention: Behavioral: The Complete Health Improvement Program
15 Recruiting Universal Cancer Peptide-based Vaccination in Metastatic NSCLC
Condition: Metastatic Non-small Cell Lung Cancer
Intervention: Drug: UCPVax
16 Completed A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer
Condition: Breast Neoplasms
Intervention: Drug: GRN163L in combination with trastuzumab
17 Recruiting Effects of TA-65, a Telomerase Activator on Metabolic Syndrome
Condition: Metabolic Syndrome X
Intervention: Dietary Supplement: TA-65
18 Completed Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma
Condition: Malignant Melanoma
Intervention: Biological: GV1001
19 Recruiting Initial Evaluation of a Telomerase-based Circulating Tumor Cell Assay in Bladder Cancer Cohorts
Condition: Urothelial Carcinoma of the Bladder
Intervention: Other: Blood Collection
20 Terminated The Effects of the Telomerase Activator TA-65 on Insulin Resistance, Inflammation, and Metabolic Syndrome
Conditions: Metabolic Syndrome;   Insulin Resistance
Interventions: Dietary Supplement: TA-65;   Dietary Supplement: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.